English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/45475

Towards a unique and transmissible vaccine against myxomatosis and rabbit haemorrhagic disease for rabbit populations

AutorAngulo, Elena ; Bárcena, Juan
Fecha de publicaciónjul-2007
EditorCSIRO Publishing
CitaciónWildlife Research, 2007, 34, 567–577
ResumenCurrently available vaccines against myxomatosis and rabbit hemorrhagic disease virus (RHDV) are not suited to immunise wild rabbit populations, as vaccines need to be delivered individually by conventional veterinary practices. As an alternative approach, research in Spain has focused on the development of a transmissible vaccine. A recombinant virus has been constructed based on a naturally attenuated myxoma virus (MV) field strain, expressing the RHDV capsid protein (VP60). Following inoculation of rabbits, the recombinant virus (MV-VP60) induced specific anti- body responses against MV and RHDV, conferring protection against lethal challenges with both viruses. Furthermore, the recombinant MV-VP60 virus showed a limited horizontal transmission capacity, either by direct contact or in a flea- mediated process, promoting immunisation of contact uninoculated animals. Efficacy and safety of the vaccine have been extensively evaluated under laboratory conditions and in a limited field trial. The development of the transmissible vaccine strategy and the steps being taken to obtain the marketing authorisation for the vaccine in the European Union are presented in this review.
Versión del editorhttp://www.publish.csiro.au/?act=view_file&file_id=WR06160.pdf
Aparece en las colecciones: (EBD) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
38662870.doc442,5 kBMicrosoft WordVisualizar/Abrir
Mostrar el registro completo

Artículos relacionados:

NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.